ea0059p093 | Diabetes & cardiovascular | SFEBES2018
Currie Gemma
, Stevens Kathryn
, Delles Christian
, McKay Gerard
Background: Evidence suggests sex-specific differences in the development and progression of diabetic nephropathy (DN). Men and women have been shown to respond differently to certain therapies and epidemiological data suggest underuse of statins and renin-angiotensin system (RAS) blocking agents in women. We evaluated our local practice to identify differences in clinical characteristics and prescribing between men and women with DN.Methods: Clinical da...